Acetohexamide

Not to be confused with acetazolamide.

Acetohexamide

Systematic (IUPAC) name
1-[(4-acetylbenzene)sulfonyl]-3-cyclohexylurea 4-acetyl-N-(cyclohexylcarbamoyl)benzenesulfonamide
Clinical data
Trade names	Dymelor
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a602021
Pharmacokinetic data
Protein binding	90%
Identifiers
CAS Number	968-81-0 Y
ATC code	A10BB31 (WHO)
PubChem	CID: 1989
IUPHAR/BPS	6793
DrugBank	DB00414 Y
ChemSpider	1912 Y
UNII	QGC8W08I6I Y
KEGG	D00219 Y
ChEBI	CHEBI:28052 Y
ChEMBL	CHEMBL1589 Y
Chemical data
Formula	C15H20N2O4S
Molecular mass	324.395 g/mol
SMILES O=C(NC1CCCCC1)NS(=O)(=O)c2ccc(C(=O)C)cc2
InChI InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19) Y Key:VGZSUPCWNCWDAN-UHFFFAOYSA-N Y
(verify)

Acetohexamide (trade name Dymelor) is a first-generation sulfonylurea medication used to treat diabetes mellitus type 2, particularly in people whose diabetes cannot be controlled by diet alone.

Mechanism of action

Acetohexamide lowers blood sugar by stimulating the pancreas to secrete insulin and helping the body use insulin efficiently. The pancreas must produce insulin for this medication to work. For this reason, acetohexamide is not used to treat diabetes mellitus type 1.

Risks

Oral hypoglycemic drugs, including acetohexamide, have been associated with increased cardiovascular mortality. Talk to your doctor about the possible risks, benefits, and alternatives of using this drug for your condition.